Nalaganje...
Emerging Diagnostic Tools to Decide When to Discontinue Nucleos(t)ide Analogues in Chronic Hepatitis B
The aim of this review is to outline emerging biomarkers that can serve as diagnostic tools to identify non-cirrhotic chronic hepatitis B (CHB) patients who could safely discontinue nucleos(t)ide analogues (NAs) before HBsAg loss. Regarding possible predictors of post-NAs outcomes, a number of studi...
Shranjeno v:
| izdano v: | Cells |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7072769/ https://ncbi.nlm.nih.gov/pubmed/32093411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9020493 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|